Pharmigene (ROCO:7595) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7595 Pharmigene Inc ROCO:7595
54 GF Score
Price NT$6.30
GF Value NT$24.76
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Pharmigene Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ROCO:7595 vs TMO, DHR, IDXX: Short Percentage of Float Comparison

For the Diagnostics & Research subindustry, Pharmigene's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmigene Short Percentage of Float vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Pharmigene's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Pharmigene's Short Percentage of Float falls into.


ROCO:7595
54GF Score
Pharmigene Inc ROCO:7595
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pharmigene (ROCO:7595) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmigene stock appears to be undervalued. The current stock price of NT$6.30 is trading 74.6% below its estimated GF Value™ of NT$24.76. GuruFocus considers Pharmigene to be Possible Value Trap.

Key valuation signals for ROCO:7595:

  • Short Percentage of Float:
  • GF Value™: NT$24.76 vs. price of NT$6.30 (74.6% below fair value)
  • GF Score™: 54/100 with 7 warning signs

No single metric tells the full story. See the ROCO:7595 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharmigene Business Description

Address No. 17, Lane 171, Section 2, Jiuzong Road, 4th Floor, Neihu District, Taipei, TWN, 11494
Pharmigene Inc is engaged in the development and sales of pharmaceutical genetic diagnostic products. Also, the company provides medical and drug testing services and equipment.
54GF Score

Get the complete analysis for ROCO:7595

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$6.30
Price
NT$24.76
GF Value